Drug therapy in the elderly

Metabolism: Clinical and Experimental

Volumn 52, Issue SUPPL. 2, 2003, Pages 27-30

  Noble, Rudolf E ^a  

^a Cathedral Hill Obesity Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTACID AGENT; ANTICOAGULANT AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORAL HYDRATE; CIMETIDINE; CLOMETHIAZOLE; CYANOCOBALAMIN; DIAZEPAM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DRUG; FUROSEMIDE; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; LEVODOPA; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PHENAZONE; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; SULFONYLUREA DERIVATIVE; THIOPENTAL; TOBRAMYCIN; UNINDEXED DRUG; WARFARIN;

AGE; AGED; AGING; AGITATION; ANTICHOLINERGIC EFFECT; ATRIOVENTRICULAR DISSOCIATION; BLEEDING; BRADYCARDIA; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG SENSITIVITY; DRUG SOLUBILITY; DRUG TISSUE LEVEL; ELDERLY CARE; EXTRAPYRAMIDAL SYMPTOM; FLUID RETENTION; GERIATRIC DISORDER; GERIATRIC PATIENT; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; HYPOTHERMIA; INCONTINENCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MENTAL DISEASE; MORBIDITY; NAUSEA; OBESITY; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SIDE EFFECT; TARDIVE DYSKINESIA; TARGET ORGAN; TISSUE SPECIFICITY; URINE RETENTION; XEROSTOMIA;

EID: 0242334031     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00298-1     Document Type: Article

References (26)

1. US Bureau of the Census: Population Projections of the U.S. by Age, Sex, Race, and Hispanic Origin. Washington, DC, US Government Printing Office, 1992
2. Col N, Fanale JE, Keonholm P: The role of medication in non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150:841-845, 1990
3. Ewing AB: Altered drug response in the elderly, in Armour D, Cairns C (eds): Medicines in the Elderly. London, UK, Pharmacological Press, 2002, pp 17, 23
4. Baron JH: Studies of basal and peak acid output with an augmented histamine test. Gut 4:136-144, 1963
5. Warren PM, Pepperman MA, Montgomery RD: Age changes in small intestinal mucosa Lancet 2: 849-850, 1978 (letter)
6. Sherlock S, Bearn AG, Billing BH, et al: Splanchnic blood flow in man by the bromosulfalein method: The relation of peripheral plasma bromosulfalein level to the calculated flow. J Lab Clin Med 35:923-932, 1950
7. Hazzard WR, Blass JP, Ettinger WH Jr, et al: Principles of Geriatric Medicine and Gerontology. New York, NY, McGraw-Hill, 1999
8. Duthrie EH Jr, Katz PR: Practice of Geriatrics. Philadelphia, PA, Saunders, 1998
9. Main A: Elderly patients and their drugs. Pharm J 240:537-539, 1988
10. Klotz U, Avant GR, Hoyampa A, et al: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55:347-359, 1975
11. Christensen JH, Andreasen F, Jansen JA: Influence of age and sex on the pharmacokinetics of thiopentone. Br J Anaesth 53:1189-1195, 1981
12. Roberts RK, Wilkinson GR, Branch RA, et al: Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium). Gastroenterology 75:479-485, 1978
13. Ritschel WA: Age-dependent disposition of amobarbital: Analog computer evaluation. J Am Geriatr Soc 26:540-543, 1978
14. Kraus JW, Desmond PV, Marshall JP, et al.: Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther 24:411-419, 1978
15. Redolfi A, Borgoelli E, Lodola E: Blood level of cimetidine in relation to age. Eur J Clin Pharmacol 15:257-261, 1979
16. Cusack B, Kelly JG, O'Malley K, et al: Digoxin in the elderly: Pharmacokinetic consequences of old age. Clin Pharmacol Ther 25:772-776, 1979
17. Vestal RE, McGuire EA, Tobin JD, et al: Aging and ethanol metabolism. Clin Pharmacol Ther 21:343-354, 1977
18. McLeod K, Hull CJ, Watson MJ: Effects of aging on the pharmcokinetics of pancuronium. Br J Anaesth 51:435-438, 1979
19. Bauer LA, Blouin RA: Influence of age on tobramycin pharmacokinetics in patients with normal renal function. Antimicrob Agents Chemother 9:587-589, 1981
20. Reidenberg MM, Erill S (eds): Drug-Protein Binding. New-York, NY, Praeger, 1986, pp 163-171
21. Calkins E, Davis PJ, Ford AB: The Practice of Geriatrics. Philadelphia, PA, Saunders, 1986
22. Rossman I: Clinical Geriatrics (ed 3). Philadelphia, PA, Lippincott, 1986
23. Tregaskis BF, Stevenson IH: Pharmacokinetics in old age. Br Med Bull 46:9-21, 1990
24. O'Malley K, Crooks J, Duke E, et al.: Effect of age and sex on human drug metabolism. Br Med J 3:607-609, 1971
25. Kragh-Sorensen P, Larsen N-E: Factors influencing nortriptyline steady-state kinetics: Plasma and saliva levels. Clin Pharmacol Ther 28:796-803, 1980
26. Skoll SL, August RJ, Johnson G: Drug prescribing for the elderly in Saskatchewan during 1976. Can Med Assoc J 121:1074-1081, 1979